MEDICAL TECHNOLOGY LIMITED

Company Registration Number:
13782311 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

MEDICAL TECHNOLOGY LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

MEDICAL TECHNOLOGY LIMITED

Balance sheet

As at 31 December 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 250,000 150,000
Tangible assets: 4 416,780 276,850
Investments: 5 116,750 385,740
Total fixed assets: 783,530 812,590
Current assets
Stocks: 1,018,725 922,510
Debtors:   0 0
Cash at bank and in hand: 112,784 87,672
Investments:   498,500 355,000
Total current assets: 1,630,009 1,365,182
Creditors: amounts falling due within one year:   0 0
Net current assets (liabilities): 1,630,009 1,365,182
Total assets less current liabilities: 2,413,539 2,177,772
Creditors: amounts falling due after more than one year:   (318,720) (226,500)
Provision for liabilities: (30,000) (30,000)
Total net assets (liabilities): 2,064,819 1,921,272
Capital and reserves
Called up share capital: 100 100
Other reserves: 650,000
Profit and loss account: 1,414,719 1,921,172
Shareholders funds: 2,064,819 1,921,272

The notes form part of these financial statements

MEDICAL TECHNOLOGY LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 14 April 2025
and signed on behalf of the board by:

Name: Abdul Rahman
Status: Director

The notes form part of these financial statements

MEDICAL TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

MEDICAL TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 24 9

MEDICAL TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Intangible Assets

Total
Cost £
At 01 January 2024 150,000
Additions 100,000
At 31 December 2024 250,000
Net book value
At 31 December 2024 250,000
At 31 December 2023 150,000

MEDICAL TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Tangible Assets

Total
Cost £
At 01 January 2024 276,850
Additions 139,930
At 31 December 2024 416,780
Net book value
At 31 December 2024 416,780
At 31 December 2023 276,850

MEDICAL TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Fixed investments

Investments made into our distribution centre which includes machinery